Monograph

The ERS Monograph is the quarterly book series from the ERS.

Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.

COPD and Comorbidity

European Respiratory Society Monograph, Vol. 59. 2013

ISBN: 978-1-84984-032-3.

DOI: 10.1183/1025448x.erm5913.

COPD is a common and progressive chronic inflammatory condition that is responsible for a large amount of morbidity and mortality globally, and affects millions of people worldwide. It is now recognised that COPD is a heterogeneous disease and that the severity of the airflow obstruction, as determined by the forced expiratory volume in 1 second (FEV1), is not the best determinant of the severity of COPD and its impacts. Thus, severity of this disease is now determined by the combination of symptoms, future risk that is mainly related to exacerbation frequency, and FEV1 stage.

Preface Eur Respir Monogr 2013; 59: v
Guest Editors Eur Respir Monogr 2013; 59: vii-viii
Introduction Klaus F. Rabe, Jadwiga A. Wedzicha, Emiel F.M. Wouters Eur Respir Monogr 2013; 59: ix-x
Prevalence of COPD and comorbidity Shambhu Aryal, Enrique Diaz-Guzman, David M. Mannino Eur Respir Monogr 2013; 59: 1-12
COPD: inflammatory mechanisms and systemic consequences Peter J. Barnes Eur Respir Monogr 2013; 59: 13-27
Assessment of cardiovascular comorbidity John D. Maclay, William MacNee Eur Respir Monogr 2013; 59: 28-49
Diagnosis and management of heart failure in COPD Frans H. Rutten Eur Respir Monogr 2013; 59: 50-63
Infection and comorbidity Richa Singh, Alexander J. Mackay, Jadwiga A. Wedzicha Eur Respir Monogr 2013; 59: 64-79
Malnutrition and obesity in COPD Erica P.A. Rutten, Emiel F.M. Wouters, Frits M.E. Franssen Eur Respir Monogr 2013; 59: 80-92
Osteoporosis in COPD Elisabeth A.P.M. Romme, Frank W.J.M. Smeenk, Emiel F.M. Wouters, Erica P.A. Rutten Eur Respir Monogr 2013; 59: 93-104
Gastro-oesophageal reflux disease and COPD Anant R.C. Patel, John R. Hurst Eur Respir Monogr 2013; 59: 105-116
Metabolic syndrome and diabetes mellitus in COPD Claire E. Wells, Emma H. Baker Eur Respir Monogr 2013; 59: 117-134
Obstructive sleep apnoea and COPD Walter T. McNicholas, Ruth Lee Eur Respir Monogr 2013; 59: 135-143
Management of depression and anxiety in COPD Paul A. Cafarella, Tanja W. Effing, Christopher Barton, David Ahmed, Peter Anthony Frith Eur Respir Monogr 2013; 59: 144-163
Managing skeletal muscle dysfunction in COPD Thierry Troosters, Wim Janssens, Marc Decramer Eur Respir Monogr 2013; 59: 164-173
Lung cancer in COPD Georgia Hardavella, Stephen Spiro Eur Respir Monogr 2013; 59: 174-188
Pulmonary hypertension in COPD Jordanna Hostler, A. Whitney Brown, John Sherner, Christopher S. King, Steven D. Nathan Eur Respir Monogr 2013; 59: 189-205
COPD and thrombosis Peter K. MacCallum Eur Respir Monogr 2013; 59: 206-216
Comorbidities in current COPD guidelines Per Sigvald Bakke Eur Respir Monogr 2013; 59: 217-222